Our Parkinson's Place: 2011-04-17

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

Thursday, April 21, 2011

Parkinson's Disease Foundation (PDF) - Hope through Research, Education and Advocacy

Tuesday, April 19, 2011

CHANGING FROM L-DOPA TO MELEVODOPA

19th April 2011 - New research
CHANGING FROM L-DOPA TO MELEVODOPA

The aim of the present study was to evaluate the use in advanced Parkinson's Disease of Melevodopa, which is undergoing testing. Continuous intravenous infusions of L-Dopa as a treatment for Parkinson's Disease are limited by the insolubility and acidity of L-Dopa. Melevodopa, which is a methyl ester of L-dopa, overcomes this as it is a soluble neutral derivative. In previous studies Melevodopa led to a significantly more rapid reversal of "off" periods, and reduction in "off" time, and

more readily led to "on" periods. In the present study, when people were switched from Sinemet to Melevodopa people improved regarding their "On-time". The benefit was greater in people with "delayed-on", and especially in those with both "delayed-on" and "wearing-off". Most patients showed a significant improvement in PDQ-39 total score (a standard Parkinson's Disease symptom questionnaire). The authors conclude that Melevodopa is an effective agent for improving daily motor performance and quality-of-life in Parkinson's Disease with "delayed-on", also in association with "wearing-off".